Log in to save to my catalogue

A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bla...

A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bla...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2360606

A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo

About this item

Full title

A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo

Publisher

London: Nature Publishing Group UK

Journal title

British journal of cancer, 2006-11, Vol.95 (10), p.1354-1361

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Minodronic acid (YM529) is a third-generation bisphosphonate (BP) that has been shown to directly and indirectly prevent proliferation, induce apoptosis, and inhibit metastasis of various types of cancer cells. In this study, we have investigated the therapeutic efficacy of YM529 against bladder cancer, both
in vitro
and
in vivo
. YM529...

Alternative Titles

Full title

A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2360606

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2360606

Other Identifiers

ISSN

0007-0920

E-ISSN

1532-1827

DOI

10.1038/sj.bjc.6603423

How to access this item